A detailed history of Ikarian Capital, LLC transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 650,000 shares of SNSE stock, worth $318,500. This represents 0.07% of its overall portfolio holdings.

Number of Shares
650,000
Previous 650,000 -0.0%
Holding current value
$318,500
Previous $403,000 3.23%
% of portfolio
0.07%
Previous 0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.59 - $1.84 $383,500 - $1.2 Million
650,000 New
650,000 $403,000

Others Institutions Holding SNSE

About Sensei Biotherapeutics, Inc.


  • Ticker SNSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,720,300
  • Market Cap $15.1M
  • Description
  • Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...
More about SNSE
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.